Fidaxomicin: A Novel Agent for the Treatment of Clostridium difficile Infection
BACKGROUND: Due to the limitations of existing treatment options for Clostridium difficile infection (CDI), new therapies are needed.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2015/934594 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832555190170943488 |
|---|---|
| author | George G Zhanel Andrew J Walkty James A Karlowsky |
| author_facet | George G Zhanel Andrew J Walkty James A Karlowsky |
| author_sort | George G Zhanel |
| collection | DOAJ |
| description | BACKGROUND: Due to the limitations of existing treatment options for Clostridium difficile infection (CDI), new therapies are needed. |
| format | Article |
| id | doaj-art-89a13fe8a91b45d38078d09084375bb6 |
| institution | Kabale University |
| issn | 1712-9532 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases and Medical Microbiology |
| spelling | doaj-art-89a13fe8a91b45d38078d09084375bb62025-02-03T05:49:27ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322015-01-0126630531210.1155/2015/934594Fidaxomicin: A Novel Agent for the Treatment of Clostridium difficile InfectionGeorge G Zhanel0Andrew J Walkty1James A Karlowsky2Department of Medical Microbiology and Infectious Diseases, College of Medicine, University of Manitoba, Winnipeg, Manitoba, CanadaDepartment of Medical Microbiology and Infectious Diseases, College of Medicine, University of Manitoba, Winnipeg, Manitoba, CanadaDepartment of Medical Microbiology and Infectious Diseases, College of Medicine, University of Manitoba, Winnipeg, Manitoba, CanadaBACKGROUND: Due to the limitations of existing treatment options for Clostridium difficile infection (CDI), new therapies are needed.http://dx.doi.org/10.1155/2015/934594 |
| spellingShingle | George G Zhanel Andrew J Walkty James A Karlowsky Fidaxomicin: A Novel Agent for the Treatment of Clostridium difficile Infection Canadian Journal of Infectious Diseases and Medical Microbiology |
| title | Fidaxomicin: A Novel Agent for the Treatment of Clostridium difficile Infection |
| title_full | Fidaxomicin: A Novel Agent for the Treatment of Clostridium difficile Infection |
| title_fullStr | Fidaxomicin: A Novel Agent for the Treatment of Clostridium difficile Infection |
| title_full_unstemmed | Fidaxomicin: A Novel Agent for the Treatment of Clostridium difficile Infection |
| title_short | Fidaxomicin: A Novel Agent for the Treatment of Clostridium difficile Infection |
| title_sort | fidaxomicin a novel agent for the treatment of clostridium difficile infection |
| url | http://dx.doi.org/10.1155/2015/934594 |
| work_keys_str_mv | AT georgegzhanel fidaxomicinanovelagentforthetreatmentofclostridiumdifficileinfection AT andrewjwalkty fidaxomicinanovelagentforthetreatmentofclostridiumdifficileinfection AT jamesakarlowsky fidaxomicinanovelagentforthetreatmentofclostridiumdifficileinfection |